Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of immune-related hepatitis and sclerosing cholangitis
jRCT1040210096Recruiting
- Sponsor
- Iwata City Hospital
- Start
- Nov 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatitis and Primary Sclerosing Cholangitis (PSC), sponsored by Iwata City Hospital. Primary endpoint: clinical course of hepatitis and sclerosing cholangitis. Started Nov 2021; status: recruiting.
02
Conditions
hepatitisPrimary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on jRCT1040210096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1040210096.